Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

New Product Launches

3 May 2018 07:00

RNS Number : 9564M
Symphony Environmental Tech. PLC
03 May 2018
 



 

 

 

 

3 May 2018

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony")

 

World First - Launch of New Latex Antimicrobial Examination Glove and Antimicrobial Healthcare Products, made with d2p technology

 

Symphony Environmental Technologies Plc (AIM: SYM), a global specialist in products and technologies that "make plastic smarter", is pleased to announce the launch today, of the first latex antimicrobial examination glove made with d2p technology.

 

Symphony is working with Health & Hygiene Ltd, a British Company and Biomax Rubber Industries of Malaysia ("Biomax"). The collaboration agreement was signed on 2 February 2018.

 

Biomax Rubber Industries Sdn Bhd is one of the fastest growing manufacturers of latex examination gloves in Malaysia and produces more than 1 billion gloves per year, certified to ISO-9001 and product certifications of ISO-13485 and CE Marking as Class I Medical Device confirming European conformity. Biomax products are sold in more than 40 countries worldwide.

 

Health & Hygiene Limited are incorporated in the UK and have been working with Symphony for some time on several projects. The antimicrobial examination gloves will be sold under the newly registered 'Protector Health & Hygiene' ("Protector®") brand.

 

The gloves are the first product launched in what is planned to be a full range of antimicrobial disposable healthcare products including face masks, caps, shoe covers, surgeon gowns, lab coats, isolation gowns, bed and pillow covers and hospital waste bags containing d2p technology.

 

The gloves themselves are the result of many years' research and development and have been designed and packaged to appeal to organisations and professionals in healthcare and food- preparation industries, where hygiene is a priority. d2p antimicrobial technology provides complete protection throughout the life of the glove by disrupting and deactivating key molecules within the bacterial cell, preventing cell replication and infection.

 

Health & Hygiene Ltd and Biomax, are exclusively incorporating the innovative d2p technology, placing the Protector® glove in a class of its own and offering 99.99% efficacy in accordance with ISO 22196 and ASTM E2180 against commonly occurring organisms including MRSA and Salmonella.

 

  

The gloves will be sold in boxes of 100 pieces or smaller boxes of 20 pieces, which are available in shelf-ready packaging, in small, medium and large sizes.

 

The launch takes place in central London and will be attended by representatives from the High Commission of Pakistan and High Commission of Malaysia as well as senior figures from the industry.

 

Michael Laurier, CEO of Symphony Environmental, commented:

 

"We are delighted with the result of the collaboration between ourselves, Biomax and Health & Hygiene Ltd, and excited by the prospect of more products becoming available in the coming months."

 

Mr Loo Chee How, Sales Director of Biomax said "We are very pleased to be working with Symphony, who not only have innovative technology, but also a worldwide distribution network."

 

Amir Younus, Executive Director of Health & Hygiene Ltd, said "The launch of the d2p examination gloves and disposable healthcare products in London today is an important milestone in our well-established business relationship with Symphony, and we look forward to introducing more products to the market with Symphony's technology."

 

 

Enquiries

Symphony Environmental Technologies Plc

 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

 

www.symphonyenvironmental.com

 

 

Cantor Fitzgerald Europe

 

David Foreman/Richard Salmond (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Alex Pollen (Sales)

 

 

Blytheweigh

 

Tim Blythe

Tel: +44 (0) 20 7138 3204

Nick Elwes

 

 

 

NOTES TO EDITORS:

 

About Symphony Environmental Technologies plc

 

Symphony has developed and continues to develop, controlled-life plastic technology which helps tackle the problem of microplastics by turning ordinary plastic at the end of its service-life into biodegradable materials. It is then no longer a plastic and can be bioassimilated in the open environment in the same way as a leaf. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world. In some countries, most recently Saudi Arabia, oxo-biodegradable plastic is mandatory.

 

To view a short BBC World Service film introducing d2w oxo-biodegradable (controlled-life) plastic technology please click on one of the following links:

 

From within the UK- http://www.symphonyenvironmental.com/d2w/d2w-brochure-5/

From outside of the UK - http://www.bbc.com/storyworks/the-british-bid/symphony

 

In addition, Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p® brand, which can be incorporated in a wide variety of plastic and non-plastic products so as to give them protection against many different types of bacteria, fungi, algae, moulds, and insects, and against fire. d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. We have also launched d2p anti-microbial household gloves and are developing a range of other d2p finished products for retail sale.

 

Symphony has also developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. This is useful to government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with 74 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

 

Symphony is a member of The Oxo-biodegradable Plastics Association (www.biodeg.org) (OPA), the Society for the Chemical Industry (UK), and the Pacific Basin Environmental Council. Symphony is also a strategic partner of the Commonwealth business initiative, and actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Symphony Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram A Symphony App is available for downloading to smartphones.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAATMBTMBBMTBP
Date   Source Headline
28th Apr 20267:00 amRNSPre-Close Trading Update
7th Apr 20267:00 amRNS-RHSAC report
23rd Mar 20267:00 amRNSDirector/PDMR dealing - Bed & ISA
18th Feb 20268:28 amRNSNew consultancy agreement and grant of options
12th Jan 20267:00 amRNS-Rd2w Biodegradable Plastic Technology
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSHolding(s) in Company
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
17th Dec 20253:33 pmRNSTrading and Middle East operations update
28th Nov 20257:00 amRNS-RAlignment with BB-REG-NET's Recommendations
26th Nov 202510:25 amRNSExtension to Convertible Loan Agreements
10th Nov 20257:00 amRNS-RNew product launch, South Korea
29th Oct 20257:00 amRNS-RRoyal Society Study on Ocean Biodegradable Plastic
24th Oct 20257:00 amRNS-RCEO speaks at Argus Fertiliser Conference
16th Oct 20257:00 amRNS-RSuccessful attendance at the K-Show
30th Sep 20257:00 amRNSInterim Results for 6 Months Ended 30 June 2025
26th Sep 20257:00 amRNS-RCEO Speaks at US SPE Conference
19th Sep 20254:55 pmRNSEPA Ireland update
23rd Jul 20251:53 pmRNSResult of AGM
23rd Jul 20257:00 amRNSAGM Statement
8th Jul 202510:25 amRNSUpdate on Approval from the Republic of Ireland
25th Jun 20251:49 pmRNSHolding(s) in Company
23rd Jun 202512:37 pmRNSApproval of d2w products in Ireland
18th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
12th Jun 20257:00 amRNSPreliminary Results
11th Jun 202510:15 amRNSChange of Subscription Amount
5th Jun 20257:00 amRNSChange of Equity Subscriber
14th May 202511:50 amRNSHolding(s) in Company
8th May 202510:35 amRNSEquity Subscription
10th Apr 20259:00 amRNSExtended Scientific Study on Microplastics in Soil
9th Apr 202510:00 amRNSTransfer of Shareholding and Assignment of CLAs
11th Mar 20257:00 amRNS-RStudy Findings - No Trace of Microplastics
10th Mar 20252:21 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNS-RRuling on Biodegradable Plastic Legislation
23rd Dec 202412:39 pmRNSOption amendments & grant of options
1st Nov 202411:15 amRNSGrant of Options
9th Sep 20247:00 amRNSInterim Results for 6 Months Ended 30 June 2024
23rd Aug 20247:00 amRNSNotice of Results and Investor Presentation
28th Jun 202412:49 pmRNSResult of AGM
28th Jun 20247:00 amRNSAGM Statement
6th Jun 20243:33 pmRNSPosting of Annual Report and Notice of AGM
6th Jun 20243:29 pmRNSPreliminary Results
23rd Apr 20244:36 pmRNSHolding(s) in Company
19th Apr 202411:16 amRNSResult of GM
3rd Apr 20242:00 pmRNSDirector dealing
28th Mar 20244:23 pmRNSResult of PrimaryBid Offer
28th Mar 20242:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.